The Maharashtra Food and Drug Administration (FDA) on Saturday withdrew its order cancelling the drug sale licence of Cipla Pharma & Life Sciences Ltd’s carrying and forwarding facility in Pune after the Bombay High Court criticised the regulator for “going overboard” in its action, reported the PTI.

HC questions FDA procedure

A bench comprising Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad observed that the FDA had acted in a “high-handed” manner and against the principles of natural justice, according to the PTI.